Literature DB >> 13852489

Psychotomimetic drugs; chemical and pharmacological aspects.

A HOFMANN.   

Abstract

Keywords:  HALLUCINOGENS/chemistry; LYSERGIC ACID DIETHYLAMIDE/related compounds

Mesh：

Substances：

Year:  1959        PMID： 13852489

Source DB:  PubMed          Journal:  Acta Physiol Pharmacol Neerl        ISSN： 0001-6748


× No keyword cloud information.
  8 in total

1.  Pharmacological studies upon neurones of the lateral geniculate nucleus of the cat.

Authors:  D R CURTIS; R DAVIS
Journal:  Br J Pharmacol Chemother       Date:  1962-04

Review 2.  The behavioral pharmacology of hallucinogens.

Authors:  William E Fantegrossi; Kevin S Murnane; Chad J Reissig
Journal:  Biochem Pharmacol       Date:  2007-07-20       Impact factor: 5.858

3.  Complete depletion of a substance in the snail brain after treatment with LSD-25.

Authors:  N N Osborne; V Neuhoff
Journal:  Naturwissenschaften       Date:  1972-08

4.  The pharmacology of neurones in the pyriform cortex.

Authors:  K F Legge; M Randic; D W Straughan
Journal:  Br J Pharmacol Chemother       Date:  1966-01

Review 5.  Preclinical models of antipsychotic drug action.

Authors:  José L Moreno; Javier González-Maeso
Journal:  Int J Neuropsychopharmacol       Date:  2013-06-10       Impact factor: 5.176

6.  Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli.

Authors:  J C Winter; J R Eckler; R A Rabin
Journal:  Psychopharmacology (Berl)       Date:  2003-11-04       Impact factor: 4.530

7.  Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines.

Authors:  J C Winter
Journal:  Psychopharmacology (Berl)       Date:  2008-11-01       Impact factor: 4.530

8.  A Complex Impact of Systemically Administered 5-HT2A Receptor Ligands on Conditioned Fear.

Authors:  Sven Melker Hagsäter; Robert Pettersson; Christopher Pettersson; Daniela Atanasovski; Jakob Näslund; Elias Eriksson
Journal:  Int J Neuropsychopharmacol       Date:  2021-09-21       Impact factor: 5.176
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.